相关实验视频

Updated: Jul 16, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

儿童糖尿病和COVID-19后的糖尿病酸症:面临的挑战和经验教训

Ashish Agarwal¹, Deepankar Bansal¹, Karthi Nallasamy¹

¹Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education & Research, Chandigarh, India.

Pediatric health, medicine and therapeutics

|September 11, 2023

概括

随着COVID-19大流行,对1型糖尿病 (T1DM) 的儿童的护理变得更糟,糖尿病酸症 (DKA) 病例增加. 对于这些脆弱的儿科患者,需要采用替代的治疗策略.

科学领域:

儿科内分泌学儿科内分泌学
传染性疾病传染性疾病
公共卫生公共卫生

背景情况:

"COVID-19"大流行严重扰乱了日常医疗保健,影响了慢性疾病管理.
儿童1型糖尿病 (T1DM) 患者在获得一致的医疗护理和随访方面面临着挑战.
对病毒传播的恐惧导致医疗保健访问减少,加剧了治疗不良遵守和延迟诊断诸如糖尿病酸性脂肪酸症 (DKA) 等并发症.

研究的目的:

在COVID-19大流行期间审查儿童T1DM和DKA管理的全球挑战.
确定在资源有限的环境中管理这些复杂案例所吸取的经验教训.
探索因大流行对糖尿病护理的影响而引发的替代解决方案.

主要方法:

这项研究采用了叙事审查方法.
它综合了COVID-19流行病对儿科T1DM和DKA管理的影响的信息.
审查重点关注全球医疗保健环境中的挑战,结果和适应性策略.

主要成果:

疫情导致T1DM儿童中复杂DKA的发病率增加,特别是在资源有限的地区.
延迟诊断,治疗不良,以及营养不良和败血症等并发症导致严重的DKA病例.
资源有限,需要创新的方法来管理儿科DKA的激增.

结论:

随着COVID-19的爆发,儿科T1DM护理系统的危急漏洞得到了凸显.
儿童T1DM和DKA的有效管理需要适应性策略,特别是在资源有限的环境中.
学到的经验教训强调了需要有弹性的医疗保健系统来管理全球卫生危机期间的慢性儿科疾病.

关键词:

在 COVID-19 疫情中,这就是SARS-CoV-2病毒.糖尿病糖尿病患者糖尿病患者凯托酸性症的发生儿科儿科儿科儿科

更多相关视频

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

相关概念视频

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...